GlassScriptPhysician profile
Michelle Gooch
NPI 1528123114
$34,882.44
in general payments reported to CMS, 2019-2025
29 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $11K · 2022: $13K · 2023: $11K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $4,513 · Consulting Fee: $3,006 · Travel and Lodging: $2,719 · Food and Beverage: $1,139.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $4,512.50 |
| Consulting Fee | $3,005.63 |
| Travel and Lodging | $2,718.69 |
| Food and Beverage | $1,138.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| United Therapeutics Corporation | $11,908.95 | 2021-2023 | Remodulin, Orenitram, Tyvaso |
| Takeda Pharmaceuticals U.S.A., INC. | $7,963.35 | 2022-2023 | Glassia |
| Grifols USA, LLC | $7,181.33 | 2021-2023 | Prolastin-C Liquid |
| Astrazeneca Pharmaceuticals LP | $2,465.66 | 2021-2023 | Tezspire, Symbicort, Breztri |
| Actelion Pharmaceuticals US, INC. | $1,694.98 | 2021-2023 | Uptravi, Opsumit |
| Glaxosmithkline, LLC. | $823.71 | 2021-2023 | Trelegy Ellipta, Nucala |
| Electromed, INC. | $590.99 | 2021-2023 | Smartvest |
| Boehringer Ingelheim Pharmaceuticals, INC. | $329.19 | 2021-2023 | Stiolto Respimat, Spiriva Respimat |
| Mallinckrodt Hospital Products INC. | $311.91 | 2021-2022 | |
| Insmed, INC. | $264.16 | 2022 | |
| Grifols Shared Services North America, INC. | $240.00 | 2023 | Prolastin-C Liquid |
| Mylan Specialty L.P. | $185.81 | 2021-2023 | Yupelri |
| Advanced Respiratory, INC | $180.45 | 2021 | |
| Genzyme Corporation | $159.32 | 2021-2022 | |
| Baxter Healthcare | $100.39 | 2022 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $66.40 | 2021-2022 | |
| Octapharma USA, INC. | $64.36 | 2021 | |
| Sanofi-Aventis U.S. LLC | $57.99 | 2022 | |
| Philips North America LLC | $55.50 | 2021 | |
| Abbvie INC. | $52.46 | 2021-2022 | |
| Vapotherm INC | $37.71 | 2022 | |
| Jazz Pharmaceuticals INC. | $37.37 | 2023 | |
| Merck Sharp & Dohme LLC | $18.51 | 2022 | |
| Genentech USA, INC. | $18.08 | 2021 | |
| Pulmonx Corporation | $17.58 | 2021 | |
| Axsome Therapeutics, INC. | $14.91 | 2023 | Sunosi |
| Bayer Healthcare Pharmaceuticals INC. | $14.50 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $14.04 | 2021 | |
| Paratek Pharmaceuticals, INC. | $12.83 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michelle Gooch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.